Prometheus Biosciences, Inc. (28)
Browse by Contract Category
Contracts
-
Underwriting Agreement, dated December 8, 2022, by and among the Registrant and Goldman Sachs & Co. LLC, SVB Securities LLC and Jefferies LLC, as representatives of the several...
(Filed With SEC on December 9, 2022)
-
Annual Incentive Plan
(Filed With SEC on March 9, 2022)
-
Description of Registered Securities
(Filed With SEC on March 9, 2022)
-
First Amendment to Lease Agreement, by and between SNH Medical Office Properties Trust and the Registrant, dated October 29, 2021
(Filed With SEC on November 12, 2021)
-
Amended and Restated Exclusive License Agreement, dated August 6, 2021, by and between Cedars-Sinai Medical Center and the Registrant
(Filed With SEC on August 11, 2021)
-
Companion Diagnostics Development and Collaboration Agreement, dated as of March 25, 2019, by and between Millennium Pharmaceuticals, Inc. and the Registrant
(Filed With SEC on February 19, 2021)
-
Amended & Restated Non-Employee Director Compensation Program
(Filed With SEC on March 9, 2022)
-
Employment Letter Agreement, dated February 7, 2021, by and between Mark Stenhouse and the Registrant
(Filed With SEC on March 8, 2021)
-
Non-Employee Director Compensation Program
(Filed With SEC on March 8, 2021)
-
Prometheus Biosciences, Inc. 2021 Employee Stock Purchase Plan
(Filed With SEC on March 8, 2021)
-
Prometheus Biosciences, Inc. 2021 Incentive Award Plan and form of stock option grant notice and stock option agreement thereunder
(Filed With SEC on March 8, 2021)
-
Specimen stock certificate evidencing the shares of common stock
(Filed With SEC on March 8, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on March 8, 2021)
-
Co-development and Manufacturing Agreement, dated as of July 30, 2020, by and between Dr. Falk Pharma GmbH and the Registrant
(Filed With SEC on February 19, 2021)
-
Amended and Restated Investors Rights Agreement, dated October 30, 2020, by and among the Registrant and certain of its stockholders
(Filed With SEC on February 19, 2021)
-
Warrant issued to Oxford Finance LLC, dated January 24, 2020
(Filed With SEC on February 19, 2021)
-
Exclusive License Agreement, dated March 22, 2019, by and between Cedars-Sinai Medical Center and the Registrant
(Filed With SEC on February 19, 2021)
-
Exclusive License Agreement, dated March 22, 2019, by and between Cedars-Sinai Medical Center and the Registrant
(Filed With SEC on February 19, 2021)
-
Exclusive License Agreement, dated September 1, 2017, by and between Cedars-Sinai Medical Center and the Registrant, as amended
(Filed With SEC on February 19, 2021)
-
Sublease Agreement, dated December 31, 2020, by and between Prometheus Laboratories Inc. and the Registrant
(Filed With SEC on February 19, 2021)
-
Loan and Security Agreement, dated January 24, 2020, by and among Oxford Finance LLC, Prometheus Laboratories, Inc. and the Registrant, as amended
(Filed With SEC on February 19, 2021)
-
Form of Indemnification Agreement for Directors and Officers
(Filed With SEC on February 19, 2021)
-
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Timothy K. Andrews and the Registrant
(Filed With SEC on February 19, 2021)
-
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Allison Luo, M.D. and the Registrant
(Filed With SEC on February 19, 2021)
-
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Keith W. Marshall, Ph.D. and the Registrant
(Filed With SEC on February 19, 2021)
-
Amended and Restated Employment Letter Agreement, dated February 17, 2021, by and between Mark C. McKenna and the Registrant
(Filed With SEC on February 19, 2021)
-
Prometheus Biosciences, Inc. 2017 Equity Incentive Plan, as amended, including form of stock option agreement thereunder
(Filed With SEC on February 19, 2021)
-
License Agreement, dated March 18, 2020, by and between Alloy Therapeutics, LLC and the Registrant
(Filed With SEC on February 19, 2021)